Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 123640-38-0, molcular formula is C11H9N5, introducing its new discovery. COA of Formula: C11H9N5
The synthesis of two copper (II) complexes, [CuBr2(C 11H9N5), compound (I), and [Cu 2Br2(ClO4)2 (C11H 9N5)2], compound (II), was investigated. The compound (II) was synthesized by adding one molar equivalent of pyrazole to the reaction mixture of compound (I). Compound (I) was a bromo-bridged dinuclear copper(II) compound stabilized by weak interactions with the perchlorate anions, while (II) was a related mononuclear species with distorted square-pyramidal geometry. In compound (I), the axial and equatorial Cu-Br bonds were found to be highly asymmetric.
One of the oldest and most widely used commercial enzyme inhibitors is aspirin, Formula: C11H9N5, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 123640-38-0
Reference：
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI